Nature Reviews Nephrology

Article	Citations
A UMOD variant with intermediate effects	624
Mentorship in the lives of scholars	368
Daratumumab for AL amyloidosis	346
Kidney health within the broader non-communicable disease agenda	338
Age-old musings: twenty-first century management of advanced kidney disease in older individuals	306
Making advance care planning easier for adults with kidney disease and their clinicians	302
The GLP-1 receptor agonist revolution comes to nephrology	296
Designing acute kidney injury clinical trials	293
Uropathogen and host responses in pyelonephritis	271
Role of the gut microbiota in the pathogenesis of IgA nephropathy	270
Vaccination in patients with kidney failure: lessons from COVID-19	219
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	210
Engineered CAR macrophages target kidney inflammation	207
Treatment of chronic kidney disease in older populations	181
Disaster preparedness for patients with kidney disease	175
Genetic determinants of urine and plasma metabolite levels	173
A single-cell atlas of DKD treatment responses	161
Daprodustat for anaemia in CKD	158
Beyond state borders: transforming dialysis care for undocumented immigrants	150
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	145
Roles of sensory receptors in non-sensory organs: the kidney and beyond	145
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	140
Non-invasive molecular imaging of kidney diseases	140
Consideration of sex differences is necessary to achieve health equity	138
Complosome — the intracellular complement system	131

Phosphate sensing via PTC glycolysis	128
Mutational signatures of ccRCC vary between geographical regions	126
Bringing Pride to nephrology	125
Reducing preventable acute kidney injury in a hospital setting	123
Publisher Correction: Sustainable Development Goals relevant to kidney health: an update on progress	121
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	119
Clonal haematopoiesis and AKI	118
Increasing diversity and inclusion in nephrology clinical trials	117
Interferon blockade in lupus: effects on antiviral immunity	116
Informing clinical decision making during a pandemic — a call for better preparedness	116
The effects of sex hormone therapy on kidney function	116
Menopause and chronic kidney disease	111
Aquaporin water channels: roles beyond renal water handling	110
The roles of hyaluronan in kidney development, physiology and disease	103
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	101
Benefits of actin cytoskeleton stabilization	101
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	98
Immunometabolic consequences of IL-23	93
From mapping kidney function to mechanism and prediction	93
ERA-EDTA congress 2021	91
NUAK1 promotes kidney fibrosis	90
Identification of erythropoietin-producing cells	90
Design of a renal-sparing antifungal	85
Tertiary lymphoid organs contribute to kidney allograft rejection	84
Treatment of SLE with anti-CD19 CAR-T cells	83
From fat to filter: the effect of adipose tissue-derived signals on kidney function	79
Salt substitution: opportunities and challenges for nephrology	79
Neutrophils and NETs in kidney disease	76
The role of complement in kidney disease	75
Heat and health inequity: acting on determinants of health to promote heat justice	74
Pathological mechanisms of kidney disease in ageing	73
Long-term health outcomes associated with hydration status	73
RNA-binding proteins and their role in kidney disease	73
The evolving landscape of immune-mediated glomerular diseases	67
Reaping the rewards of mechanistic discovery in glomerular disease	64
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	60
A golden year of innovative kidney disease therapeutics	58
An integrated approach towards a public health perspective on chronic kidney disease	57
A pathway of osmotic stress-induced necroptosis	57
Network medicine: an approach to complex kidney disease phenotypes	56
Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	55
MSC therapy for diabetic kidney disease and nephrotic syndrome	54
Reducing stress-induced CHOP is renoprotective	53
Patient-centred approaches for the management of unpleasant symptoms in kidney disease	52
Self-reactive innate-like B-1 cells infiltrate grafts	52
Combination therapy for kidney disease in people with diabetes mellitus	52
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	52
New insights into the ccRCC microenvironment	51
Consequence of microvascular inflammation in transplantation	51
Ketogenic diet benefits in critically ill patients with sepsis	49

Consequences of famine and malnourishment on kidney health	49
CKD-specific ASCVD risk prediction tools	49
Transcatheter mitral valve repair in patients with CKD	47
The cilia mechanosensation debate gets (bio)physical	47
Educating primary healthcare providers about kidney disease	46
Continuing kidney care in conflicts	46
Kidney complications of parasitic diseases	46
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function	44
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	44
Role of the cGAS–STING pathway in systemic and organ-specific diseases	44
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	44
Gene therapy in a model of nephrotic syndrome	43
Mechanism of B cell survival in lupus nephritis	43
Dietary protection of proximal tubules in diabetes	40
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	40
Targeting IL-1Ra to attenuate fungal infection	39
The kidney is a novel target of metformin	38
Nephrology education and training in Africa	38
Multifaceted innovations needed to advance transplant nephrology	37
Born too soon: lifelong kidney risks and the importance of early intervention	36
Mannose as a driver of γδ T cell kidney infiltration	36
Steps forward in the treatment of IgA nephropathy	34
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	34
A guide to gene–disease relationships in nephrology	34
Chronic cardiovascular–kidney disorder: a new conceptual framework	31
Role of necroptosis in kidney health and disease	31
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	30
Metabolic alterations in hereditary and sporadic renal cell carcinoma	30
A multidisciplinary approach to cardiorespiratory fitness in CKD	30
Epithelial cell states associated with kidney and allograft injury	30
ALCAM–CD6 in lupus nephritis	29
Fasting induces structural and functional changes in the peritoneal membrane	29
Insights into the impact of pregnancy on kidney disease	28
Derivation of collecting duct organoids	28
Author Correction: Therapeutic advances in COVID-19	27
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	27
Tissue-resident memory T cells in the urogenital tract	25
Acute kidney injury in patients with burns	25
The impact of intrauterine growth restriction and prematurity on nephron endowment	24
The perils of misinformation: when health literacy goes awry	24
From big data to smart decisions: artificial intelligence in kidney risk assessment	24
Strategies to achieve gender equity in nephrology	23
Renal nerves in physiology, pathophysiology and interoception	23
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	23
Cryo-EM structure of AVP–V2 receptor complex	22
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	22
Switching off SOX9 for epithelial recovery after AKI	22
Digital determinants of health: opportunities and risks amidst health inequities	21
Hope for resistant hypertension through BrigHTN and PRECISION	21
Crosstalk between glomeruli and tubules	20
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	20
CD38 — a new target in renal immune disease	20
Impact of persistent conflict and destabilizing events on dialysis care	19
Collagen formation, function and role in kidney disease	19
The impact of population ageing on the burden of chronic kidney disease	19
The genetics of kidney stone disease and nephrocalcinosis	18
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	18
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	18
Chlorthalidone in advanced CKD	18
Nephrology and women’s health post-Roe v. Wade: we must do better	18
Application of spatial-omics to the classification of kidney biopsy samples in transplantation	17
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis	16
Pathogenic cellular and molecular mediators in lupus nephritis	16
Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases	16
Multi-omics integration in the age of million single-cell data	16
Podocyte-targeted therapies — progress and future directions	16
Bridging the gap of referral to nephrology care	15
Deep learning applications in digital pathology	15
Use of kidneys from SARS-CoV-2 infected donors	14
P3H2 in glomerular basement membrane regulation	14
Cellular senescence: the good, the bad and the unknown	14
Increased PD1 signalling in kidney ageing	14
Anti-tumour antibody-producing plasma cells disseminate from tertiary lymphoid structures	14
Publisher Correction: Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	13
Trained immunity: from kidney failure to organ transplantation	13
Progress towards solving the donor organ shortage	13
mTORC1 under the control of CB1R	13
Insights into glomerular function and disease pathogenesis	12
New evidence of the impact of mitochondria on kidney health and disease	12
New and emerging therapies for diabetic kidney disease	12

Belzutifan: a novel therapy for von Hippel–Lindau disease	12
Gasdermins and pyroptosis in the kidney	11
TRPM channels in health and disease	11
Calcium phosphate crystals: targets for renoprotection	11
The evolving story of apolipoprotein L1 nephropathy: the end of the beginning	11
Vascular damage in systemic lupus erythematosus	11
Pharmacogenomics in the clinic	11
Advances and challenges in kidney fibrosis therapeutics	11
Important roles of mechanical force and hydraulic pressure in kidney function	11
Author Correction: Beyond state borders: transforming dialysis care for undocumented immigrants	10
SGLT2 inhibitors may prevent diabetes	10
Thiazides in kidney transplant recipients: skin in the game	10
The impact of the Russian–Ukrainian war for people with chronic diseases	9
Cystatin C and the misdiagnosis of CKD in older adults	9
Diuretics in patients with chronic kidney disease	9
Managing climate change risks is imperative for human health	9
Clonal haematopoiesis, ageing and kidney disease	9
Inflammation and gut dysbiosis as drivers of CKD–MBD	9
Cell and gene therapy for kidney disease	9
The genetics and pathogenesis of CAKUT	8
ECM remodelling by ADAMTS12 in fibrosis	8
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies	8
The role of lysosomes in metabolic and autoimmune diseases	8
KIM-1 targeted extracellular vesicles for AKI	8
Targeting OSBPL7 restores cholesterol efflux	8
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential	8
Opioids for chronic pain management in patients with dialysis-dependent kidney failure	8
Electronic patient-reported outcomes in chronic kidney disease	8
Ferroptotic stress promotes the AKI to CKD transition	8
Disasters and kidney care: pitfalls and solutions	8
Advances in CRISPR therapeutics	8
Advancing gender equity to improve kidney care for women: a patient perspective	7
Youth-onset type 2 diabetes mellitus: an urgent challenge	7
Kidney and heart failure outcomes associated with SGLT2 inhibitor use	6
A guide to studying 3D genome structure and dynamics in the kidney	6
New insights into kidney crosstalk with distant organs	6
Progress in xenotransplantation: overcoming immune barriers	6
Circulating osteopontin mediates acute kidney injury-induced respiratory failure	6
Avenciguat reduces albuminuria in patients with chronic kidney disease	6
Intersectionality as a lens for achieving kidney health justice	6
Chronic kidney disease and the global public health agenda: an international consensus	6
VISTA dampens T cell activation in injured kidney	6
Synchronization in the renal microcirculation	6
Remodelling by macula densa cells	6
Activin A in CKD-associated muscle wasting	6
Epidemiology of haemodialysis outcomes	6
The pathogenesis of pre-eclampsia in kidney donors	5
Including sexual orientation and gender identity data to advance nephrology care	5
Amino acid metabolism in kidney health and disease	5
Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS	5
Long-term lessons from EMPA-KIDNEY	5
Paths to organ damage and risk factors in AKI	5
Drug repurposing for glomerular diseases: an underutilized resource	5
The intelligent podocyte: sensing and responding to a complex microenvironment	5
Diagnosis of cardiovascular disease in patients with chronic kidney disease	4
Removal of small, asymptomatic kidney stones	4
A polygenic score predicts CKD across ancestries	4
Inequities in kidney health and kidney care	4
UTX regulates accumulation of lipids via kidney serine	4
Targeting iron uptake to correct T cell dysfunction	4
Iron deficiency of kidney macrophages in CKD	4
Post-translational modifications in kidney diseases and associated cardiovascular risk	4
Protective circulating proteins in DKD	4
Sex differences in kidney metabolism and DKD	4
A new pathway links iron sensing with histone demethylation and regulation of mTORC1 activity	4
Macrophages clean out the tubules	3
Mutational fingerprints reconstruct human cell genealogies	3
Propagation of acute kidney injury	3
Association of metabolic dysfunction-associated fatty liver disease with kidney disease	3
AngII autoantibodies after SARS-CoV-2 infection	3
Leveraging lysine metabolism for renoprotection	3
Senolytics for kidney repair	3
Kidney benefits of SLGT2 inhibitors: evidence from clinical trials	3
Reply to ‘Use of convalescent plasma in the treatment of COVID-19’	3
The importance of sex and gender in basic and clinical research	3
Sexual orientation and gender identity in organ and tissue donation and transplantation	3
Neuroprotective effect of RAS inhibitors	3
NCKs are essential to podocyte–GBM interactions	3
Ensuring health equity for sexual and/or gender minority individuals	3
Benefits of CoQ10 supplementation in patients with SRNS due to primary CoQ10 deficiency	3
Improving outcomes in glomerular disease	3
AURORA 1 reports efficacy of voclosporin in lupus nephritis	3
The roles of tertiary lymphoid structures in chronic diseases	3
Overcoming barriers to deliver high quality kidney care	3
Protein handling in kidney tubules	3
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia	3
Embryo complementation to generate a humanized mesonephros in pigs	2
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease	2
Hypertension-induced cognitive impairment: from pathophysiology to public health	2
Pathogenesis of autoimmune disease	2
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia	2
Fiji’s rising tide: the growing burden of diabetic kidney disease on emerging nephrology services	2
Artificial intelligence approaches to enable early detection of CKD	2
Activation and regulation of alloreactive T cell immunity in solid organ transplantation	2
New AAV vector targets glomerular endothelial cells	2